Arcus Biosciences (RCUS)

Arcus Biosciences (RCUS-N) is currently facing financial challenges as it is losing money, which raises caution for potential investors. This situation has led experts to classify it as a speculative stock, indicating that it carries a higher level of risk. Prospective buyers are advised to limit their exposure by ensuring they hold no other speculative stocks within their portfolios. The recommendation leans towards adopting a cautious approach, emphasizing that this stock should fit within a broader strategy that minimizes overall risk. Despite the potential upside, investors should remain vigilant and conduct thorough research before considering any investment in Arcus Biosciences.